Edition:
United Kingdom

Nightstar Therapeutics PLC (NITE.OQ)

NITE.OQ on NASDAQ Stock Exchange Global Select Market

13.01USD
15 Dec 2017
Change (% chg)

$-0.61 (-4.48%)
Prev Close
$13.62
Open
$13.43
Day's High
$13.90
Day's Low
$12.68
Volume
5,030
Avg. Vol
34,865
52-wk High
$24.70
52-wk Low
$12.49

Chart for

About

Nightstar Therapeutics PLC, formerly Nightstar Therapeutics Limited, is a clinical-stage gene therapy company. The Company is focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness. The Company is developing a... (more)

Overall

Beta: --
Market Cap(Mil.): $470.69
Shares Outstanding(Mil.): 28.10
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Nightstar Therapeutics announces pricing of initial public offering

* Pricing initial public offering of 5.4 million American Depositary Shares at $14 per ADS for total gross proceeds of about $75 million Source text for Eikon: Further company coverage:

28 Sep 2017

Earnings vs. Estimates